Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Brad S. Kahl
Emerging Therapy for the Treatment of Mantle Cell Lymphoma
Journal of the National Comprehensive Cancer Network : JNCCN
Medicine
Oncology
Duvelisib, an Oral Dual PI3K-δ,γ Inhibitor, Shows Clinical and Pharmacodynamic Activity in Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma in a Phase 1 Study
American Journal of Hematology
Hematology
Maintenance Rituximab or Observation After Frontline Treatment With Bendamustine-Rituximab for Follicular Lymphoma
British Journal of Haematology
Hematology
Prognostic Variables of Progression Free Survival in Mantle Cell Lymphoma After Autologous Stem Cell Transplantation
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Evaluation of Sulfonamide Detoxification Pathways in Haematologic Malignancy Patients Prior to Intermittent Trimethoprim-Sulfamethoxazole Prophylaxis
British Journal of Clinical Pharmacology
Pharmacology
Differences in Quality of Life Between Bendamustine-Rituximab and R-Chop/R-CVP in Patients With Previously Untreated Advanced Indolent Non-Hodgkin Lymphoma or Mantle Cell Lymphoma
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
VcR-CVAD Induction Chemotherapy Followed by Maintenance Rituximab Produces Durable Remissions in Mantle Cell Lymphoma: A Wisconsin Oncology Network Study
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Multicenter Phase II Study of Bortezomib in Patients With Relapsed or Refractory Mantle Cell Lymphoma
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
